Eastern Mediterranean (WHO region) vs Israel: Treatment success rate: XDR-TB cases
Eastern Mediterranean (WHO region)
74
in 2022
Israel
100
in 2022
Eastern Mediterranean (WHO region) rank
1st
Israel rank
1st
Treatment success rate: XDR-TB cases over time
- Eastern Mediterranean (WHO region)
- Israel
How they compare
Israel currently reports 100 against 74 in Eastern Mediterranean (WHO region), a difference of 26.
That makes Israel's figure about 1.4 times Eastern Mediterranean (WHO region)'s.
The two have swapped places 8 times across 13 shared years of data; in 2008 it was Israel ahead.
Eastern Mediterranean (WHO region) ranks 1st and Israel ranks 1st of 11 groups.
Across the 3 decades both report, Eastern Mediterranean (WHO region) averaged higher in 1 and Israel in 2.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 100 | 100 | Israel |
| 2010s | 41.56 | 55.56 | 14 | Israel |
| 2020s | 72 | 60 | 12 | Eastern Mediterranean (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Eastern Mediterranean (WHO region) or Israel?
- Israel, at 100 against 74 in Eastern Mediterranean (WHO region) as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Eastern Mediterranean (WHO region) and Israel?
- 26, with Israel ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and Israel?
- 13 years are reported by both, from 2008 to 2022.
- How do Eastern Mediterranean (WHO region) and Israel rank globally for treatment success rate: xdr-tb cases?
- Eastern Mediterranean (WHO region) ranks 1st and Israel ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.